The Early Stage Trader presentation by Jeff Brown blown people away, but did you know that the biggest investing event in 400 years is coming?
Learn more about Jeff Brown check out the Jeff Brown investor page now.
Listen, the number of Biotech companies getting funds right now is out of this world. We haven't seen such a tech boom since the late 90s/early 2000s. That's why it's the perfect time to make some money with Early Stage Trader.
You see, Jeff Brown is one of a handful of people around the world that cracked the “timed stocks” code. He's able to pinpoint the potential biotech stock's skyrocketing moment to a second thanks to the built-in timer.
On top of that, he back-tested these types of stocks with 100% accuracy. Like the BOAA stock skyrocketing to 17,400% and PTGEF by 84,900% in a single day. Do you know anyone else that can do that?
Click Here to get EarlyStageTrader
Early Stage Trader: BioTech Stocks
While Biotech stocks have been a big deal for nearly two decades nothing compares to where they are at now. The global situation we're experiencing has accelerated biotech companies to new heights.
Jeff Brown understands that and even has the data to prove it. For example, 100% of the 179 biotech stocks that he backtested since December went up at a predetermined time.
We’re talking stocks like MRN going up 852% in one day all the way to the previously mentioned 84,900% gain of PTGEF in a single day. Here are a few of the stocks Jeff mentioned:
- MRN: 852% in a day
- HGEN: 873%
- VXRT: 1,182%
- TMBR: 1,386%
- NVAX: 1,349%
- MIR.V: 1,650%
- IBIO: 1,742%
- OBMP: 1,983%
- BIEI: 2,400%
- GTHR: 2,455% in 5 days
- GNPX: 2,490%
- IMMB: 2,900%
- BOAA: 17,400% in a day
- PTGEF: 84,900% in a day
However, Jeff Brown is not the only person that picked up on this trend as even a quick search online reveals STATNews calling it the start of ‘biotech century’ or BIO.org saying that ‘Biotech is the Key to Post-Pandemic Resilience.’
But Only Early Stage Trader Shows You Where To Invest
Top Jeff Brown's Biotech Companies?
There is no denying that this is the next phase of the already popular Biotech revolution. Just look at the returns of some of the biotech stocks in 2019 compared to 2020.
This is just a small sample of the more popular biotech stocks but right away you can see there were some big winners and a couple of losers. However, the bigger picture you need to look at is the movement. Things change pace quickly, and while the opportunity to invest into biotech stocks is bigger than ever it might be your last chance.
What does that mean? Should you jump on the Biotech stock-picking bandwagon and just buy everything you can?
That seems to be the case with most traders and investors out there, but there is a better way.
Jeff Brown’s Top Biotech Stock Picking Method Inside Early Stage Trader
You see, Jeff Brown came out with a method, which he backtested on hundreds of biotech stocks to a 100% accuracy, on how to select these biotech shares and know exactly when these ‘Timed Stocks’ can skyrocket. This is no longer a theory, it’s science.
I can’t go into exact details on how he picks them, you can watch his explanation Here, but there are basically 3 requirements.
- The company must be funded
- Have an IPO
- Schedule a big event
Sounds simple, right? Well, Jeff goes into more detail in the video, but it’s not rocket science. If you know what to look for all you need is Jeff’s method and a brokerage account to spot them.
Jeff’s idea was to pick stocks he can be as certain as a trader can about its potential. In fact, he even offers 2 guarantees with the Early Stage Trader: 100% your money back credit, and over combined 1,000% in gains in the next 12 months or you get a year for free.
While you can’t predict the future to a pinpoint and should only invest what you are prepared to lose, such guarantees make it easier to invest with confidence. After all, Jeff Brown is the #1 Angel investor in America.
Get Jeff Brown Number One Biotech Stock
Jeff Brown Reviews
Jeff Brown has been called everything from a maverick to a genius in the trading world. However, some facts about him are certain:
- On the Russell 1,000, Jeff Brown selected the top 2 small-caps (odds of that are 1 in 500 million)
- He’s a 2 times picker of the number 1 stock on the S&P 500
- 121 out of 130 private deals he made are up as much as 4300%
- Yale is about to engrave Jeff Brown’s name on their Founders Wall
- On top of that, he has either training or degrees from top universities like Purdue, Stanford, MIT, and London Business School
However, his greatest achievement, according to himself, is quitting the corporate world and focusing on what he calls ‘Time Stocks’ like the ones we discussed above. Now while Jeff enjoyed what he did, there was no time for anything else. His family, friends, and hobbies always took second place.
Tired of this cycle Jeff started to develop the 3-step method that allowed him to identify stocks early, sometimes months, weeks, or even days, and know exactly when they will spike.
This allowed him to easily duplicate this method and spend time where it really matters, with his loved ones on his own terms. He’s his own boss and pays himself really well.
How about you? Are you ready to get out of the rat race and live on your own terms?
Join Jeff Brown Investor in doing that Now
Inside Review of Early Stage Trader 2021 Newsletter
The bread and butter of Early Stage Trader is the membership to Jeff Brown's biotech stocks picks newsletter. It’s 12 monthly issues (with special offer through this LINK you get 2 years/ 24 issues) with new recommendations for each month.
This month'S Timed Stock is set to spike on March 24th at 8:30 AM EST, so you still have time for a potential $142,000 profit on this trade. There are also 3 more trades to 10x your money
- Timed Stock #1 is set to spike on April 10.
- Timed Stock #2 is set to spike on April 17.
- Timed Stock #3 is set to spike on May 10.
However, it’s not one of those newsletters where you get a recommended trade and are left to play it how you please. No, each issue explains the play in details which includes why Jeff Brown and his team picked the stock for the month and how you can get your hands on it.
With that said, you’re not required to read the full review of each stock if you don’t want to. You can simply follow the timing and price up to recommendations. However, I do like to understand a bit more about what I’m investing in.
Early Stage Trader Portfolio
Want all the Jeff Brown’s EST recommendations in one place? The portfolio is where you want to look as it features all of the open positions with information on Open Dates, Open Prices, Recent Prices, Dividend returns, Buy Up to Prices, and the Stop Loss.
I’ll be honest that portfolio is where I spend most of my time with Early Stage Trader as it shows me the true potential of the newsletter and Jeff Brown. More importantly, its proof to me that Jeff is not some fly-by guru or a one-hit-wonder. He’s been getting results for more than 25 years and it shows.
EST Email Alerts
Now, getting monthly recommendations is great but what about sell orders, quick opportunities that cannot wait a whole month?
Well, Jeff sends out regular email alerts so you don’t have to be checking the EST website for any news on the trades. You will get all the updates in your personal email account.
Early Stage Trader Bonuses
- Jeff Brown’s Legacy Conference Presentation – The speech Jeff gave about changes to America that includes quantum computing, future of AI, 5G, and augmented reality are revolutionary.
- The Early Stage Trader Manifesto – get the exact blueprint on how to pick Timed Stocks with the potential for 1,000%+ gains like Jeff Brown does. This way you’ll have his picks and your own to increase the profits.
Get It While You Still Can
Why I Trust Jeff Brown Top Biotech Stock Picks
You don’t need to be a 40-year-old stock market veteran to know that entering an early stage of stock can yield massive gains. After all, if you bought Google, Amazon, or Apple at the right time you would have been set for life.
However, the above stocks happen once in blue moon and even then, it takes them years to reach their true potential. The biotech stocks Jeff Brown is targeting take months at most, and mostly it’s weeks or even days before the possibility of a big payday.
Like the stock that is set to skyrocket on March 24th, 2021.
That’s why I follow Jeff Brown and his recommendations. Unlike hedge funds or even trading gurus, Jeff allows me to invest a little and possibly gain a lot. I mean Jeff guarantees that the overall portfolio will gain 1000%, in 12 months or you get a year for free. He's not making that guarantee lightly.
Do you know the performance rate of some of the best hedge funds in the world? They hover at around 30% at best and you need a fortune to even get in.
Do you see the difference? With Jeff Brown’s Early Stage Trader I can take $5,000 and possibly 10x it or even 100x.
That means I could turn $5,000 into $50,000 with 1,000% gain overall. While at one of the best hedge funds I would need to invest $150,000 at 30% to make the same $5,000 profit as I did with Jeff.
Do you see why I trust and follow Jeff? It’s simple, Early Stage Trader makes me money without putting my savings and retirement at risk with Jeff Brown's #1 biotech stock
Click Here to Get Early Stage Trader now and if this review helped you please consider using a different email when getting the EST than you used for the presentation.
The Early Stage Trader Reviews
EST Newsletter - 90%
EST Portfolio - 95%
ETS Alerts - 92%